ARCHIVES

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Techniques Developing Out Of Virus research Leading To Improved Therapy, Early Diagnosis

March 4, 1977

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

In Brief: Kalt Named Director, NCI extramural Div.; Browning Is Deputy; Other DEA Staff Changes

June 10, 1994

House DoD Report Provides $15 Million For Lung Cancer Screening

October 23, 2009

Fewer New Grants Funded Under President’s Proposal.

February 11, 2000